PRPS1-Related Charcot-Marie-Tooth Neuropathy X Type 5

PRPS1-related Charcot-Marie-Tooth neuropathy X type 5 (often called CMTX5) is a very rare, inherited nerve disease. It mainly affects the long nerves of the arms and legs, the hearing nerve, and the optic (eye) nerve. The main signs are weakness and wasting of the hands and feet, very early severe hearing loss, and loss of vision from damage to the optic nerve. PubMed+1

PRPS1-related Charcot-Marie-Tooth neuropathy X type 5 (often called CMTX5) is a very rare inherited nerve disease. It happens because of a change (mutation) in a gene called PRPS1 on the X chromosome. This gene helps make an enzyme that is needed to build nucleotides, which are small building blocks used by cells to make DNA, RNA, and energy molecules. When PRPS1 does not work properly, long nerves in the arms and legs slowly become damaged. PMC+1

CMTX5 has a typical “triad” of problems: peripheral neuropathy (weakness and numbness in legs and arms), early and severe hearing loss, and optic neuropathy or optic atrophy, which can reduce vision. Symptoms usually start in childhood with clumsy walking, foot drop, or frequent falls. Later, people may need braces, walking aids, or wheelchairs. Because this condition is X-linked, it usually affects boys more severely, while some girls who carry the mutation may be mildly affected or even appear normal. PubMed+2MalaCards+2

This disease is caused by a change (mutation) in a gene called PRPS1 on the X chromosome. The PRPS1 gene gives instructions to make an enzyme called phosphoribosyl pyrophosphate synthetase 1 (PRS-1). This enzyme is important for making building blocks of DNA and RNA (nucleotides). When the enzyme does not work well, the nerves do not get enough of these building blocks, so they cannot keep long nerve fibers healthy. PMC+2NCBI+2

CMTX5 is passed on in an X-linked recessive way. This means boys are usually more strongly affected, because they have only one X chromosome. Girls may have no symptoms or only mild problems, because they have two X chromosomes and the working copy can partly protect them. PubMed+1

CMTX5 belongs to a group of PRPS1-related disorders. Changes in the same PRPS1 gene can also cause non-syndromic deafness (DFN2), Arts syndrome, or PRPS1 “superactivity”. These conditions form a “continuum,” with different levels of enzyme activity and different levels of nerve damage, hearing loss, and other problems. PMC+2Wiley Online Library+2

Because CMTX5 is so rare (fewer than 1 in 1,000,000 people worldwide), most doctors see very few cases. Diagnosis is usually made in childhood when a child has early deafness, gait problems, and later vision loss, and genetic testing finds a PRPS1 mutation. malacards.org+1

Other names and types

CMTX5 has several other names in the medical literature. These names can be confusing, but they all point to the same core condition: an X-linked neuropathy caused by PRPS1 mutations. PubMed+1

Some other names include:

1. Charcot-Marie-Tooth disease, X-linked recessive, type 5

2. Charcot-Marie-Tooth neuropathy X type 5 (CMTX5)

3. Rosenberg–Chutorian syndrome (older name)

4. PRPS1-related Charcot-Marie-Tooth neuropathy

5. PRPS1-related CMTX5

These names reflect the pattern (X-linked), the affected system (peripheral nerves), and the gene (PRPS1). PubMed+2malacards.org+2

Doctors now understand that PRPS1-related disease can appear in several clinical types or variants. These are based on which symptoms are strongest: PMC+2DNB+2

1. Classic CMTX5 type – This is the “triad” of severe early hearing loss, length-dependent peripheral neuropathy (weakness and wasting in hands and feet), and optic atrophy (loss of optic nerve fibers), usually starting in childhood. PubMed+1

2. CMTX5 without optic atrophy – Some patients have hearing loss and neuropathy but little or no optic nerve damage, showing a milder eye picture. thejcn.com+1

3. Mild CMTX5 with mainly hearing loss – In some families, the main feature is prelingual (before speech) sensorineural deafness with only subtle neuropathy signs, overlapping with DFN2. PMC+1

4. Overlap with Arts syndrome – When the enzyme level is even lower, patients can show features of Arts syndrome, such as ataxia, infections, and more severe neurological problems, together with neuropathy and hearing loss. NCBI+2ScienceDirect+2

5. Intermediate female phenotype – Some females with a PRPS1 mutation develop a mixed picture of CMTX5 and Arts-like signs, due to how the X chromosome is switched on and off in their cells (X-inactivation). DNB+1

Causes

The main cause of PRPS1-related CMTX5 is a harmful mutation in the PRPS1 gene. Below are 20 related factors and mechanisms that together explain why the disease appears and why it can be more or less severe in different people.

1. PRPS1 loss-of-function mutation
   A change in the DNA code of the PRPS1 gene reduces or blocks the function of the PRS-1 enzyme. This can be a single “letter” change (missense), a small deletion, or another variant that weakens enzyme activity. PMC+2snu.elsevierpure.com+2

2. X-linked recessive inheritance pattern
   Because PRPS1 lies on the X chromosome, boys who inherit a faulty copy usually develop the full disease, while girls may be carriers with mild or no symptoms. This inheritance pattern explains why most reported CMTX5 patients are male. PubMed+2deciphergenomics.org+2

3. Missense mutations that change key amino acids
   Most reported CMTX5 cases have missense mutations that replace important amino acids in the PRS-1 protein. These changes can disturb the enzyme’s active site or structure, so it cannot bind its normal substrates properly. PMC+2Wiley Online Library+2

4. Mutations that reduce enzyme stability
   Some mutations make the PRS-1 protein unstable. The body then breaks it down faster, so there is less enzyme available in nerve cells, leading to chronic shortage of nucleotides. NCBI+1

5. Impaired dimer or multimer formation of PRS-1
   PRS-1 normally works as part of a dimer or larger complex. Mutations can disturb the way enzyme units stick together, which lowers overall activity and further reduces nucleotide production. Europe PMC+1

6. Shortage of phosphoribosyl pyrophosphate (PRPP)
   PRS-1 makes PRPP, a key molecule for building purine and pyrimidine nucleotides. When PRPP levels are low, nerve cells cannot make enough DNA/RNA building blocks and high-energy molecules, which harms long nerves. NCBI+1

7. Disturbed purine nucleotide synthesis
   Reduced PRPP leads to reduced purine (adenine and guanine) production. These molecules are vital for ATP and GTP, which power many reactions in neurons, especially in long axons of peripheral and optic nerves. NCBI+1

8. Disturbed pyrimidine nucleotide synthesis
   Pyrimidines (cytosine, thymine, uracil) also depend on PRPP. Low pyrimidine levels affect RNA and DNA repair and maintenance in nerve cells, making them more fragile over time. NCBI+1

9. High metabolic demand in long peripheral nerves
   Peripheral nerves in arms and legs are very long, so they need strong energy supply and fast repair. Because of the PRPS1 defect, these long nerves suffer earlier and more severely than shorter nerves, causing the typical “length-dependent” neuropathy. PubMed+2malacards.org+2

10. Vulnerability of the auditory nerve
    The hearing (auditory) nerve and inner ear hair cells have high energy needs. Early and profound hearing loss in CMTX5 reflects how sensitive these cells are to nucleotide shortage and mitochondrial stress. PubMed+2thejcn.com+2

11. Vulnerability of the optic nerve
    The optic nerve is another long, heavily myelinated nerve bundle. In CMTX5, low PRPS1 activity leads to progressive optic neuropathy and optic atrophy, with slow loss of visual function. PubMed+2Wiley Online Library+2

12. Skewed X-inactivation in females
    In carrier females, one X chromosome is turned off in each cell. If more cells shut down the healthy X and keep the mutated X active, a woman can show neuropathy, vision, or hearing problems similar to milder CMTX5. This pattern is called skewed X-inactivation. DNB+1

13. Family history of PRPS1-related disorders
    Families with PRPS1 mutations may have members with CMTX5, Arts syndrome, DFN2, or mixed features. Having relatives with these conditions increases the chance that a boy who inherits the mutated gene will develop CMTX5. PMC+2DNB+2

14. De novo (new) mutations in PRPS1
    Sometimes, a PRPS1 mutation appears for the first time in a child, without any family history. This is called a de novo mutation and still leads to enzyme deficiency and CMTX5 symptoms. thejcn.com+1

15. Genetic modifiers in other genes
    Other genes involved in nerve function, mitochondrial health, or purine metabolism may modify how serious the symptoms are. This may explain why some patients with the same PRPS1 mutation have different levels of weakness or vision loss. DNB+2Nature+2

16. Stress from febrile (fever) illnesses
    Some patients with CMTX5 show repeated episodes of worsening weakness after fever or infections. Fever increases metabolic stress on already fragile nerves, so symptoms can temporarily flare up or progress faster. ScienceDirect+1

17. Possible sensitivity to certain medicines or toxins
    Nerves that already lack nucleotides may be more sensitive to medicines or toxins that harm mitochondria or interfere with purine metabolism. While this is not the main cause, it can worsen existing neuropathy. NCBI+1

18. Delayed diagnosis and lack of supportive care
    If CMTX5 is not recognized early, children may not receive hearing aids, mobility aids, physiotherapy, or vision support. This does not cause the disease, but it can lead to more disability and complications over time. PubMed+1

19. Poor general nerve health from other conditions
    Other medical problems like vitamin B12 deficiency, diabetes, or thyroid disease can harm nerves. When they occur together with CMTX5, they can further lower nerve function, making the inherited neuropathy appear more severe. NCBI+1

20. Unknown or yet-unidentified factors
    Because only a small number of patients with CMTX5 have been reported, there may be additional genetic or environmental factors that affect onset age, speed of progression, or severity, which scientists are still studying. ScienceDirect+2Wiley Online Library+2

Symptoms

1. Progressive distal muscle weakness
   Weakness usually starts in the feet and legs and later in the hands. Children may fall often, struggle to run, or find it hard to climb stairs. Over time, hand weakness can make it difficult to hold small objects or button clothes. PubMed+2malacards.org+2

2. Muscle wasting (atrophy) in hands and feet
   Because the nerves do not send strong signals, the small muscles in the feet, lower legs, and hands slowly shrink. The lower legs can look “thin” below the knees, and the hands may look bony. PubMed+1

3. Foot drop and gait disturbance
   Weak ankle muscles cause the front of the foot to drop. The child may lift the knees high to avoid dragging the toes, causing a “steppage gait.” This is often one of the first visible signs of CMTX5. PubMed+2thejcn.com+2

4. Early, severe sensorineural hearing loss
   Most boys with CMTX5 are born with or develop very early deafness affecting both ears. This hearing loss is sensorineural, meaning it comes from damage to inner ear structures or the auditory nerve. It often appears before the child starts to speak (prelingual). PubMed+2thejcn.com+2

5. Progressive optic neuropathy and visual loss
   Vision usually worsens later than hearing. Damage to the optic nerve leads to decreased visual sharpness and pale optic discs on eye exam (optic atrophy). Some patients develop severe vision loss in adolescence or adulthood. PubMed+2Wiley Online Library+2

6. Numbness and reduced sensation in feet and hands
   Children and adults can feel tingling, “pins and needles,” or numbness in their feet and hands. They may not notice small injuries, which increases the risk of skin damage and infections. PubMed+2malacards.org+2

7. Loss of tendon reflexes
   Reflexes like the knee-jerk and ankle-jerk are often weak or absent. This is a typical sign of peripheral neuropathy when the reflex arc is damaged. PubMed+2thejcn.com+2

8. Balance problems and unsteady walking
   Because of weakness and loss of joint position sense, patients may sway when standing or walking, especially in the dark or with eyes closed. This increases the risk of falls. PubMed+1

9. Hand coordination problems
   Fine motor tasks such as writing, drawing, fastening buttons, or using tools may become hard due to weakness and sensory loss in the hands, making school and daily activities more challenging. PubMed+1

10. Foot deformities (pes cavus and hammer toes)
    Over time, muscle imbalance around the feet can cause high-arched feet (pes cavus), curved toes, and other deformities. These can make shoe fitting difficult and cause pressure sores. PubMed+2malacards.org+2

11. Fatigue and reduced exercise tolerance
    Because muscles are weak and nerve signals are poor, patients may become tired quickly when walking or standing. They may need frequent rest or mobility aids as they grow. PubMed+1

12. Occasional neuropathic pain or discomfort
    Some patients report burning, shooting pain, or uncomfortable tingling in the feet or legs. This neuropathic pain comes from irritated or dying nerve fibers. Not everyone with CMTX5 has pain, but it can occur. PubMed+1

13. Developmental motor delay in childhood
    Because of early neuropathy and hearing loss, some children sit, stand, or walk later than usual. They may need extra support with physiotherapy and hearing services to reach developmental milestones. PubMed+2thejcn.com+2

14. Communication difficulties due to deafness
    Severe early hearing loss can make speech development slow or limited. Many children need sign language, cochlear implants, or powerful hearing aids to help with communication and learning. PubMed+2thejcn.com+2

15. Possible mild cognitive or behavioral issues in overlap cases
    In classic CMTX5, thinking ability is usually normal. However, in cases overlapping with Arts syndrome, some patients may have learning difficulties, attention problems, or behavioral changes. NCBI+2ScienceDirect+2

Diagnostic tests

Doctors use a mix of clinical examination, nerve tests, lab studies, imaging, and genetic testing to confirm PRPS1-related CMTX5 and to rule out other causes of neuropathy, hearing loss, and vision loss. PubMed+2thejcn.com+2

Physical examination tests

1. Full neurological examination
The doctor checks muscle strength, tone, tendon reflexes, and sensation in all four limbs. Weakness and wasting in the lower legs and hands, loss of ankle reflexes, and reduced vibration or position sense suggest a length-dependent peripheral neuropathy typical of CMTX5. PubMed+2malacards.org+2

2. Gait and posture assessment
Watching the patient walk, run, and stand on heels and toes helps the doctor see foot drop, steppage gait, and balance problems. These signs support the diagnosis of a motor-sensory neuropathy affecting distal muscles. PubMed+2thejcn.com+2

3. Cranial nerve and hearing-vision screening
The doctor checks eye movements, facial strength, and simple hearing and vision tasks. Early severe hearing loss and signs of optic nerve dysfunction (reduced visual acuity, color vision problems) point toward the classic CMTX5 triad. PubMed+2thejcn.com+2

4. Eye examination with ophthalmoscopy
An ophthalmologist looks inside the eyes with a special light to examine the optic disc. Pale, thinned optic discs show optic atrophy, a key feature of CMTX5 and related PRPS1 disorders. PubMed+2Wiley Online Library+2

Manual bedside tests

5. Manual muscle testing (MRC scale)
The doctor tests each muscle group by asking the patient to push or pull against resistance and scores strength on a standard scale. This simple test maps which muscles are weak and tracks changes over time. PubMed+2malacards.org+2

6. Vibration and joint position sense testing
Using a tuning fork and moving toes or fingers up and down, the examiner tests large-fiber sensory function. Loss of vibration and position sense in the feet is common in CMTX5 and confirms involvement of sensory nerves. PubMed+1

7. Romberg and balance tests
The patient is asked to stand with feet together, first with eyes open, then closed (Romberg test), and to walk in a straight line. Swaying or falling with eyes closed suggests sensory ataxia from peripheral nerve damage. PubMed+2malacards.org+2

8. Simple bedside hearing tests (whispered voice and tuning fork)
Whispered voice tests and tuning fork tests (Rinne and Weber) help distinguish sensorineural hearing loss from conductive loss. In CMTX5, these manual tests typically show bilateral severe sensorineural hearing loss. PubMed+2thejcn.com+2

Lab and pathological tests

9. General blood tests and metabolic screen
Basic blood work (full blood count, vitamin B12, thyroid function, glucose) helps rule out other causes of neuropathy, such as diabetes or vitamin deficiencies. In CMTX5 these tests are often normal, but they are important to exclude other treatable conditions. NCBI+1

10. Specialized studies of purine metabolism and PRPS1 enzyme activity
In some centers, doctors can measure PRS-1 enzyme activity in blood cells or skin fibroblasts, and may study purine and pyrimidine levels. Reduced PRS-1 activity supports a diagnosis of PRPS1 deficiency, helping to distinguish CMTX5 or Arts syndrome from other neuropathies. NCBI+1

11. Genetic testing for PRPS1 mutations
Genetic testing is the key confirmatory test. DNA from blood is analyzed using a targeted CMT gene panel, exome sequencing, or direct PRPS1 sequencing. Finding a pathogenic PRPS1 variant in a patient with the clinical triad confirms PRPS1-related CMTX5. thejcn.com+2ResearchGate+2

12. Nerve biopsy (rarely needed now)
In older reports, a sural nerve biopsy was sometimes done, showing loss of myelinated fibers and chronic axonal neuropathy. Today, because genetic tests are widely available, nerve biopsy is rarely needed and is reserved for unclear cases. PubMed+2thejcn.com+2

Electrodiagnostic tests

13. Nerve conduction studies (NCS)
NCS measure how fast and strong electrical signals travel along peripheral nerves. In CMTX5, results usually show reduced amplitudes and sometimes slowed conduction in motor and sensory nerves, confirming a sensorimotor neuropathy. PubMed+2thejcn.com+2

14. Electromyography (EMG)
EMG records the electrical activity of muscles using tiny needles. It shows signs of long-standing denervation (loss of nerve supply) and re-innervation, which match a chronic axonal neuropathy seen in CMTX5. PubMed+2thejcn.com+2

15. Brainstem auditory evoked responses (BAER/ABR)
This test measures electrical responses from the hearing nerve and brainstem after sound clicks. In CMTX5, BAER often shows absent or very abnormal waves, confirming severe sensorineural hearing loss and auditory pathway involvement. PubMed+2thejcn.com+2

16. Visual evoked potentials (VEP)
VEP measures the brain’s electrical response to visual patterns. In patients with optic neuropathy, the waves are delayed or reduced, which confirms damage to the optic nerve and supports the diagnosis. PubMed+2Wiley Online Library+2

Imaging tests

17. MRI of the brain and optic nerves
Magnetic resonance imaging can show thinning of the optic nerves and sometimes cerebellar or brainstem changes in PRPS1-related disease. These findings, together with clinical and genetic results, help describe the full extent of nervous system involvement. DNB+1

18. MRI of the spine or plexus (when needed)
Spine or plexus MRI is not always required, but in some patients it helps exclude other causes of neuropathy, such as spinal cord compression or inflammatory disease, when the picture is unclear. Usually, imaging is normal in pure CMTX5. PubMed+1

19. Optical coherence tomography (OCT)
OCT is a non-invasive imaging test that scans the retina and optic nerve head. It can show thinning of the retinal nerve fiber layer in patients with optic neuropathy, giving a quantitative measure of optic nerve damage in CMTX5 and related PRPS1 syndromes. Springer+1

20. Inner ear imaging (CT or MRI of the temporal bone)
CT or MRI of the temporal bones may be done to look at the inner ear and auditory nerve. In CMTX5, this imaging often appears structurally normal, but it helps exclude other ear malformations or tumors as causes of the severe hearing loss. PubMed+2thejcn.com+2

Non-pharmacological Treatments (Therapies and Others)

1. Regular physical therapy (physiotherapy)
   Physical therapy uses gentle stretching, strengthening, and balance exercises to keep muscles and joints working as well as possible. The purpose is to slow loss of strength, keep joints flexible, and delay contractures (stiff, shortened muscles). It works by regularly moving and loading the muscles and joints so they do not become weak or frozen from disuse. Studies in CMT show that strength and endurance training can improve function and daily activities. PMC+1

2. Occupational therapy (OT)
   Occupational therapists help people manage everyday tasks such as dressing, writing, typing, cooking, or using a phone when their hands and feet are weak. The purpose is to keep independence in daily life. OT works by teaching easier ways to do tasks, suggesting special tools (adaptive equipment), and changing how activities are done to reduce strain on weak muscles. Muscular Dystrophy Association+1

3. Ankle–foot orthoses (AFOs) and other braces
   Braces such as AFOs support weak ankle muscles, lift the front of the foot, and improve walking. The purpose is to reduce tripping and falls and make walking safer and less tiring. They work by holding the ankle in a more stable position and helping with foot clearance during each step. Evidence in CMT suggests orthoses can improve gait, though results vary between people. PMC+1

4. Mobility aids (cane, crutches, walker, wheelchair)
   As weakness progresses, some people with CMTX5 need aids to move safely. The purpose is to prevent falls, save energy, and allow longer distances with less fatigue. These aids work by giving extra support, spreading weight more evenly, and reducing the demand on weak leg muscles. Using mobility aids early can actually help people stay active instead of becoming home-bound. Muscular Dystrophy Association+1

5. Balance and gait training
   Special training with a therapist can improve how a person walks and keeps balance. The purpose is to lower fall risk and to teach safer walking patterns, for example by widening the stance or using visual cues. It works by practicing repeated movements that re-train the brain and body to use remaining muscle strength more efficiently and safely. PMC+1

6. Hearing aids and cochlear implant rehabilitation
   Most people with CMTX5 have early, severe sensorineural hearing loss. Digital hearing aids or cochlear implants can help them hear speech and sounds better. The purpose is to improve communication, social interaction, and learning. Audiology rehabilitation works by training the brain to use amplified or electrical sound signals, with repeated listening exercises and communication strategies. PMC+1

7. Low-vision rehabilitation and visual aids
   When optic neuropathy or optic atrophy reduces vision, vision rehab can help. The purpose is to maximize the use of remaining sight. Therapists use tools like high-contrast print, magnifiers, better lighting, screen readers, and training to scan the environment. This works by adapting the environment and teaching new visual habits instead of trying to fix the damaged optic nerve. MalaCards+1

8. Foot care and podiatry
   Numb feet can easily get unnoticed injuries. Regular checks by a podiatrist, nail care, and good shoes are very important. The purpose is to prevent ulcers, infections, and deformity. Foot care works by spotting early problems, treating calluses and ingrown nails, and choosing shoes that protect the foot and support weak muscles. Mayo Clinic+1

9. Pain psychology and cognitive-behavioural therapy (CBT)
   Chronic nerve pain and disability can cause stress, low mood, and sleep problems. Pain psychology uses CBT, relaxation, and coping skills. The purpose is to reduce the emotional impact of pain and improve quality of life, even if pain is not fully removed. It works by changing unhelpful thoughts about pain and teaching practical mental tools to manage it. cmtausa.org+1

10. Supervised aerobic exercise (swimming, cycling, walking)
    Gentle aerobic activity can help maintain heart health, mood, and overall function. The purpose is to stay as fit as possible without over-straining weak muscles. It works by improving blood flow, endurance, and metabolism. Research in CMT suggests that well-planned strength and endurance training is generally safe and can improve daily activity levels. PMC+1

11. Energy conservation and fatigue management
    Many people with neuropathy feel tired easily. Therapists can teach how to plan the day, pace activities, and rest before exhaustion. The purpose is to use limited energy wisely, so important tasks are still possible. It works by spreading heavy tasks across the week, mixing harder and easier jobs, and using aids to save effort. Muscular Dystrophy Association+1

12. Home safety and fall-prevention modifications
    Simple changes like grab bars, non-slip mats, removing loose rugs, and good lighting reduce fall risk. The purpose is to prevent fractures, head injuries, or hospital stays. This works by removing tripping hazards and giving the person something to hold for balance in risky spots such as bathrooms and stairs. Mayo Clinic+1

13. Ergonomic changes at school or work
    Adjusted desks, special chairs, adapted keyboards, and voice-to-text software can make study or work easier. The purpose is to protect weak hands and feet from overuse and to allow continued education and employment. It works by fitting the environment to the person instead of forcing the person to fit the environment. Muscular Dystrophy Association+1

14. Genetic counselling for family planning
    Because PRPS1-related CMTX5 is X-linked, families may want information about inheritance and risks to children. The purpose is to allow informed decisions about having children, carrier testing, and prenatal or preimplantation genetic testing. It works by explaining how the gene is passed on and discussing options in a non-judgmental way. thejcn.com+1

15. Education and peer support groups
    Meeting others with Charcot-Marie-Tooth disease can reduce loneliness and provide practical tips. The purpose is emotional support and sharing experience. It works by building a community where people understand each other’s challenges and successes. Muscular Dystrophy Association+1

16. Nutritional counselling and weight management
    Extra weight makes walking harder and increases strain on weak ankles and knees. A dietitian can help set a healthy eating plan. The purpose is to keep a safe weight and good general health. It works by balancing calories, increasing nutrient-dense foods, and avoiding big swings in blood sugar and energy. Mayo Clinic+1

17. Sleep and respiratory monitoring (if disease is severe)
    Some neuropathies can affect breathing or cause sleep apnoea. In advanced CMT, sleep studies or pulmonary tests may be used. The purpose is to detect breathing problems early and treat them with masks or other devices. It works by checking oxygen and breathing patterns at night and supporting breathing if needed. Mayo Clinic+1

18. Avoiding nerve-toxic medicines and triggers
    Certain chemotherapy drugs (for example vincristine) and some other medicines can damage nerves and are usually avoided in people with CMT. The purpose is to prevent further nerve injury. It works by carefully reviewing all prescribed and over-the-counter medicines with the doctor and choosing safer options when possible. Mayo Clinic+1

19. Vaccination and infection prevention
    In some reports, weakness worsened after fever or infections in CMTX5. Staying up to date with vaccines and treating infections promptly may reduce these flares. The purpose is to avoid strong immune and fever responses that can stress already-damaged nerves. It works by giving protection against common infections such as flu and pneumonia. ScienceDirect+1

20. School accommodations and special education support
    Children with CMTX5 may have hearing, vision, and mobility problems at school. Support such as front-row seating, extra time on tests, sign language, or large print materials can help. The purpose is to allow equal learning chances. It works by adjusting teaching methods and classroom setups to the child’s needs. PMC+1

---

Drug Treatments

Important safety note: The drugs below are examples used for neuropathic pain and related problems. Many are approved by the U.S. FDA for other causes of nerve pain (such as diabetic neuropathy or post-herpetic neuralgia), not specifically for PRPS1-related CMTX5. Doses are general adult ranges from prescribing information, not personal advice. Always follow a specialist’s instructions. FDA Access Data+4FDA Access Data+4FDA Access Data+4

Because of length, each medicine is summarized more briefly than 100 words but still explained clearly.

1. Gabapentin (Neurontin)
   Class: Anticonvulsant / gabapentinoid.
   Use: Widely used for neuropathic pain. FDA-approved for post-herpetic neuralgia and partial seizures. FDA Access Data+2FDA Access Data+2
   Typical adult dose: Often started around 300 mg per day and slowly increased; many adults reach 900–1800 mg/day or more in divided doses, adjusted for kidney function (from FDA label; doctors individualize). FDA Access Data+1
   Mechanism: Binds to calcium channels in nerve cells and reduces release of excitatory neurotransmitters, lowering abnormal pain signals.
   Common side effects: Sleepiness, dizziness, swelling of legs, weight gain, and sometimes mood changes.

2. Pregabalin (Lyrica / Lyrica CR)
   Class: Anticonvulsant / gabapentinoid.
   Use: FDA-approved for several neuropathic pain conditions (diabetic neuropathy, post-herpetic neuralgia, spinal cord injury) and fibromyalgia. FDA Access Data+2FDA Access Data+2
   Dose: Often 150–300 mg/day in divided doses for neuropathic pain, adjusted to kidney function (per label; exact dose set by doctor). FDA Access Data+1
   Mechanism: Similar to gabapentin, reducing abnormal firing in pain pathways.
   Side effects: Drowsiness, dizziness, weight gain, blurred vision, oedema, possible mood changes.

3. Duloxetine (Cymbalta)
   Class: Serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant.
   Use: FDA-approved for diabetic peripheral neuropathic pain, fibromyalgia, depression, anxiety. FDA Access Data+2FDA Access Data+2
   Dose: Commonly 30–60 mg once daily, sometimes increased to 60 mg twice daily in adults (label guidance).
   Mechanism: Increases serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord, which can reduce pain messages.
   Side effects: Nausea, dry mouth, sleep changes, sweating, increased blood pressure, and suicidal thoughts warning in young people.

4. Amitriptyline
   Class: Tricyclic antidepressant (TCA).
   Use: Long-used for neuropathic pain and poor sleep, although usually off-label. NCBI+1
   Dose: Adults often start as low as 10–25 mg at night and may slowly increase; higher doses mainly for depression.
   Mechanism: Blocks reuptake of serotonin and norepinephrine and affects pain pathways; also has sedative effect that may improve sleep.
   Side effects: Dry mouth, constipation, weight gain, drowsiness, heart rhythm problems in some patients.

5. Nortriptyline
   Class: Tricyclic antidepressant.
   Use: Similar to amitriptyline, often used when amitriptyline causes too many side effects.
   Dose: Often 10–25 mg at bedtime, slowly increased as tolerated.
   Mechanism: Modulates pain signalling through serotonin and norepinephrine pathways with slightly fewer anticholinergic side effects than amitriptyline.
   Side effects: Dry mouth, dizziness, constipation, possible heart rhythm changes.

6. Lidocaine 5% patch (Lidoderm)
   Class: Local anaesthetic (topical).
   Use: FDA-approved for post-herpetic neuralgia; often used for localized neuropathic pain. FDA Access Data+2FDA Access Data+2
   Dose: Up to three patches applied to intact skin for up to 12 hours in 24 hours (from FDA labelling; doctor adjusts).
   Mechanism: Blocks sodium channels in nerve endings in the skin, reducing pain signal generation.
   Side effects: Local redness, irritation; rare systemic toxicity if used incorrectly.

7. Capsaicin 8% patch (Qutenza)
   Class: Topical capsaicin (TRPV1 receptor agonist).
   Use: FDA-approved for neuropathic pain associated with post-herpetic neuralgia; used in some other neuropathic pain cases under specialist care. FDA Access Data+2FDA Access Data+2
   Dose: Patch applied by trained staff for a set time; treatment may be repeated every few months.
   Mechanism: Strong stimulation then “defunctionalisation” of pain fibres so they send fewer signals.
   Side effects: Burning sensation during and shortly after application, redness, temporary pain flare.

8. Non-steroidal anti-inflammatory drugs (NSAIDs – e.g., ibuprofen, naproxen)
   Class: NSAID pain relievers.
   Use: Help with musculoskeletal pain, joint strain, headache; less effective for pure nerve pain but sometimes helpful in mixed pain.
   Dose: Varies by drug (for example ibuprofen 200–400 mg every 6–8 hours for adults, within maximum daily limits, per product label).
   Mechanism: Block COX enzymes and reduce inflammatory prostaglandins.
   Side effects: Stomach upset, ulcers, kidney strain, and increased bleeding risk, especially with long-term use.

9. Acetaminophen (paracetamol)
   Class: Analgesic and antipyretic.
   Use: Mild to moderate pain or fever; often combined with other methods.
   Dose: Usually up to 3–4 g/day maximum in adults from all sources, lower in liver disease (per label).
   Mechanism: Likely acts in the brain to reduce pain and fever; not truly anti-inflammatory.
   Side effects: Liver damage with overdose or in high-risk patients.

10. Tramadol
    Class: Weak opioid plus SNRI-like action.
    Use: For moderate to severe pain when first-line drugs are not enough; should be used carefully.
    Dose: Often 50–100 mg every 4–6 hours as needed in adults within maximum limits, under close medical supervision.
    Mechanism: Binds to opioid receptors and inhibits reuptake of serotonin and norepinephrine, reducing pain messages.
    Side effects: Nausea, dizziness, constipation, dependence risk, seizures in some people, and serotonin syndrome if combined with other serotonergic drugs.

11. Topical lidocaine gel or cream
    Similar to lidocaine patches but in cream or gel form. Used for small painful areas such as the tops of feet. Mechanism and side effects are similar: local sodium channel block with mainly skin irritation as a side effect.

12. Baclofen
    Class: Muscle relaxant, GABA-B agonist.
    Use: For painful muscle spasms or stiffness if present.
    Mechanism: Decreases excitability of motor neurons in the spinal cord, relaxing muscles.
    Side effects: Sleepiness, weakness, dizziness; sudden stop can cause withdrawal.

13. Tizanidine
    Class: Alpha-2 adrenergic agonist muscle relaxant.
    Use: For spasticity and some types of muscle tightness.
    Mechanism: Reduces excitatory input to motor neurons.
    Side effects: Sedation, low blood pressure, dry mouth, liver issues.

14. Sertraline or other SSRI antidepressant
    Class: SSRI.
    Use: For depression or anxiety related to chronic illness; improved mood can also make pain easier to manage.
    Mechanism: Increases serotonin levels in brain circuits that control mood.
    Side effects: Nausea, sleep changes, sexual side effects, weight changes, and suicidal thoughts warning in adolescents.

15. Melatonin (as a medicine in some countries)
    Class: Sleep-regulating hormone analogue.
    Use: Helps regulate sleep–wake cycle when pain and disability disturb sleep.
    Mechanism: Acts on melatonin receptors in the brain to align circadian rhythm.
    Side effects: Drowsiness, vivid dreams, headache in some users.

16. Vitamin B12 injections (when deficient)
    Class: Vitamin replacement.
    Use: Treats B12 deficiency neuropathy; not specific to CMTX5 but important if blood tests show low levels.
    Mechanism: Supports myelin and nerve metabolism.
    Side effects: Usually mild (injection site pain); rare allergy.

17. Alpha-lipoic acid (in some countries as a registered medicine)
    Sometimes used for diabetic neuropathy. It is an antioxidant that may improve nerve blood flow and reduce oxidative stress, though evidence is mixed and mainly in diabetes, not CMTX5. Palliative Care Network of Wisconsin

18. Topical capsaicin low-dose cream
    Over-the-counter cream with low-dose capsaicin can help mild localized nerve pain by reducing substance P in nerve endings. Temporary burning is common at the start.

19. Opioid analgesics (stronger opioids)
    In severe pain that fails other options, specialists may consider stronger opioids. Because of high risk of tolerance, dependence, constipation, and overdose, they are usually a last resort and used at the lowest effective dose for the shortest time.

20. Medications for associated conditions (for example anti-epileptic drugs, migraine medicines, blood pressure control)
    These are not specific to CMTX5 but are sometimes needed to treat associated problems in the same patient. Management should be individualized by a neurologist.

---

Dietary Molecular Supplements

Supplements can interact with medicines. Always ask a doctor or pharmacist before using them, especially in a rare genetic disease.

1. Alpha-lipoic acid
   An antioxidant used in some countries for diabetic neuropathy. Usual doses in studies are around 600 mg/day. It may improve nerve blood flow and reduce oxidative stress, which could indirectly support nerve health. The function is to mop up free radicals and support energy production in mitochondria. Mechanism is experimental in CMTX5 and evidence is mainly from diabetic neuropathy.

2. Acetyl-L-carnitine
   This nutrient helps move fatty acids into mitochondria for energy. Doses in studies range from 500–2000 mg/day. It may support nerve regeneration and reduce pain in some neuropathies by improving energy supply and reducing oxidative damage. Evidence is limited and not specific to PRPS1-related neuropathy.

3. Omega-3 fatty acids (EPA/DHA)
   Found in fish oil, these healthy fats have anti-inflammatory effects. Typical supplement doses are 1–3 g/day of combined EPA and DHA. They help stabilize nerve cell membranes and may reduce low-grade inflammation in the body. Their main function is general heart and brain support, not a direct cure for CMTX5.

4. Vitamin B1 (thiamine or benfotiamine)
   Thiamine is needed for energy metabolism in nerves. Doses in supplements are often 50–300 mg/day. It may support nerve conduction in deficiency states. Benfotiamine is a fat-soluble form used in some neuropathy studies. Too much is rarely toxic, but balance with other B vitamins is better.

5. Vitamin B6 (pyridoxine – with caution)
   B6 is important for neurotransmitter synthesis. Low levels can cause neuropathy, but too much B6 can also damage nerves, so doses should usually stay under about 50 mg/day unless directly supervised by a physician. The function is mainly enzymatic support in amino acid metabolism.

6. Vitamin B12 (methylcobalamin)
   Supports myelin and DNA synthesis. Oral doses often range from 500–2000 mcg/day; injections are higher but less frequent. In deficiency, B12 replacement can improve neuropathy. In normal levels, extra B12 may not give further benefit, but it is often used because it is generally safe.

7. Vitamin D3
   Many people with chronic illness live indoors and have low vitamin D. Doses vary widely; common maintenance doses are 800–2000 IU/day, adjusted by blood levels. Vitamin D supports bone health, muscle function, and immune regulation, which indirectly helps mobility and overall health.

8. Magnesium
   Magnesium is involved in nerve conduction and muscle relaxation. Typical doses are 200–400 mg/day of elemental magnesium, depending on the preparation. It may help with muscle cramps or restless legs in some people. Too much can cause diarrhoea or, in kidney disease, elevated magnesium levels.

9. Coenzyme Q10 (CoQ10)
   A component of the mitochondrial electron transport chain. Doses often range from 100–300 mg/day. It may support cellular energy and act as an antioxidant. Some small studies suggest benefit in mitochondrial disorders; there is no direct evidence in CMTX5 but it is sometimes tried for general nerve support.

10. Curcumin (from turmeric)
    Curcumin has anti-inflammatory and antioxidant properties. Supplement doses vary (for example 500–1000 mg/day of standardized extract). It may help with general inflammation and joint aches. Absorption can be low; some products add piperine or use special formulations to improve uptake.

---

Immunity-Related, Regenerative and Stem-Cell-Type Approaches

There are no approved “immunity booster” or stem-cell drugs for PRPS1-related CMTX5. The ideas below are research or general concepts, not standard treatments.

1. Optimized vaccination schedule
   Vaccines (like flu and pneumonia vaccines) are not classic “drugs for CMTX5”, but they help the immune system fight infections. Because some CMTX5 patients became weaker after severe fever, preventing infections may indirectly protect nerve function. ScienceDirect+1

2. Intravenous immunoglobulin (IVIG) – for other neuropathies
   IVIG is a blood product used for immune-mediated neuropathies (like CIDP or Guillain–Barré), not for CMTX5. It provides pooled antibodies that modulate immune responses. In PRPS1-related CMTX5, it is not standard and would only be considered if an additional immune neuropathy is suspected.

3. Experimental gene therapy
   Research in other genetic neuropathies explores viral vectors that deliver a correct copy of a gene to nerve cells. For PRPS1, such work is still at the level of theory and maybe early lab studies; there is no approved therapy. Gene therapy works by trying to restore a working gene, but long-term safety and effectiveness must be tested in trials.

4. Experimental stem-cell therapies
   In some neuromuscular diseases, researchers are studying mesenchymal stem cells or neural stem cells. The idea is that these cells might release growth factors that support damaged nerves. For CMTX5, evidence is extremely limited; any such treatment should only occur in well-regulated clinical trials, not in commercial “stem cell clinics.”

5. Neurotrophic-factor based drugs (research stage)
   Drugs that increase protective nerve growth factors (like NGF, BDNF, or G-CSF analogues) are being studied for various neuropathies. These agents aim to support nerve survival and regrowth. None are approved specifically for PRPS1-related disease.

6. Support of mitochondrial and nucleotide metabolism
   Because PRPS1 is involved in nucleotide synthesis, some scientists speculate that targeting energy and nucleotide pathways might help. This could include experimental small molecules that adjust purine–pyrimidine balance. At present, this is a scientific idea, not an available therapy.

---

Surgeries – Procedures and Why They Are Done

1. Tendon transfer surgery for foot drop
   When ankle muscles are very weak, surgeons can move a working tendon (for example from a stronger muscle) to help lift the foot. The purpose is to reduce tripping and improve walking without relying only on braces. It is done when conservative measures no longer give enough stability.

2. Foot deformity correction (osteotomy, fusion)
   Long-standing weakness can cause high-arched or very flat feet and clawed toes. Surgery can realign bones (osteotomy) or sometimes fuse joints to create a stable, plantigrade foot. The purpose is to reduce pain, fit shoes better, and prevent ulcers.

3. Spine surgery for severe scoliosis (if present)
   Some people with neuromuscular diseases develop scoliosis. When the curve is large or causes pain or breathing problems, spinal fusion surgery may be suggested. The purpose is to correct spinal alignment and improve posture and lung function.

4. Cochlear implant surgery for profound deafness
   In severe sensorineural hearing loss, cochlear implants can bypass damaged hair cells and directly stimulate the hearing nerve. The purpose is to improve hearing and speech understanding in people whose hearing aids are not enough. Rehabilitation after surgery is essential. PMC+1

5. Eye surgeries for other eye problems
   Optic atrophy itself is not surgically fixable, but people with CMTX5 may still develop cataracts or other eye conditions like anyone else. Surgery for these conditions (for example cataract extraction) is done to improve any treatable part of vision and to reduce glare or blur.

---

Prevention Strategies

While you cannot prevent the gene mutation, you can lower complications:

1. Genetic counselling before planning children.

2. Avoiding nerve-toxic medications such as vincristine and discussing all new drugs with the neurologist. Mayo Clinic+1

3. Keeping vaccinations up to date to reduce risk of severe infections and fever spikes. ScienceDirect+1

4. Daily foot checks, proper shoes, and regular podiatry to prevent ulcers and infections.

5. Regular physical therapy and safe exercise to keep muscles and joints as strong and flexible as possible. PMC+1

6. Early use of braces or mobility aids to prevent falls and fractures.

7. Home safety modifications (grab bars, good lighting, no loose rugs).

8. Healthy weight, no smoking, and low alcohol to support nerves and overall health. Mayo Clinic+1

9. Regular hearing and vision checks for early fitting of aids. PMC+1

10. Scheduled follow-ups with a neuromuscular clinic so changes are noticed early and treatment plans updated. Muscular Dystrophy Association+1

---

When to See a Doctor

You should see a doctor (preferably a neurologist with experience in inherited neuropathies) as soon as possible if:

• A child has early walking problems, frequent falls, or foot drop.

• There is sudden worsening of weakness after a fever or infection. ScienceDirect+1

• Pain becomes strong enough to disturb sleep or daily life.

• Hearing suddenly worsens or speech becomes hard to understand.

• Vision becomes more blurred, colours seem faded, or there are new problems seeing in dim light. MalaCards+1

• New numbness, burning, or tingling appears in hands or feet.

• There are frequent trips, falls, or near-falls at home or outside.

• Mood becomes very low, or there are thoughts of self-harm (this needs emergency help).

• Any medicine seems to cause new weakness, rash, severe dizziness, or allergy symptoms.

• You are planning surgery, pregnancy, or new strong medicines and need advice specific to CMTX5.

---

What to Eat and What to Avoid

1. Eat: A balanced diet rich in vegetables, fruits, whole grains, and lean protein to support general health and muscle repair.

2. Eat: Foods with healthy fats (fish, nuts, seeds, olive oil) for brain and nerve cell membranes.

3. Eat: Sources of B-vitamins and iron (meat, eggs, dairy, legumes, leafy greens) unless your doctor says otherwise.

4. Eat: Calcium and vitamin-D-rich foods (milk, yoghurt, fortified plant milks, small fish with bones) for bone health.

5. Eat: Enough fluids and fibre to avoid constipation, especially if you take pain medicines.

6. Avoid: Very high sugar and ultra-processed foods that cause weight gain and energy crashes.

7. Avoid: Excess alcohol, which can damage nerves and worsen balance. Mayo Clinic+1

8. Avoid: Smoking and vaping, because they reduce blood flow to nerves and muscles.

9. Avoid: Crash diets or extreme fasting that cause muscle loss.

10. Avoid: Supplements or “miracle cures” sold online without strong medical evidence, especially expensive stem-cell or “nerve regeneration” products without proper clinical trials.

---

Frequently Asked Questions (FAQs)

1. Is PRPS1-related CMTX5 curable?
   No. At present there is no cure or gene-correcting treatment. Care focuses on managing symptoms, protecting function, and improving quality of life. PubMed+2PMC+2

2. Does everyone with CMTX5 lose vision and hearing?
   Most reported patients have severe early hearing loss, and many have optic neuropathy, but some families show partial or different patterns. The exact symptoms depend on the specific PRPS1 mutation and other factors. PMC+2thejcn.com+2

3. How fast does the disease progress?
   CMTX5 is usually slowly progressive. Children may walk normally at first, then develop gait problems and weakness over years. Hearing and vision usually decline early but then stabilize or slowly worsen. PubMed+1

4. Can exercise make the neuropathy worse?
   Properly planned, low-impact exercise is generally helpful, not harmful. Over-exercising to the point of exhaustion or pain is not recommended. A therapist should design an individualized program. PMC+1

5. Are there special vitamins that stop the disease?
   No vitamin has been proven to stop PRPS1-related neuropathy. Vitamins can correct deficiencies and support general health but cannot fix the underlying gene problem.

6. Can gene therapy help now?
   Gene therapy for CMTX5 is still in the research and discussion stage. There are no approved clinical gene-therapy treatments yet for PRPS1-related disease.

7. Why are pain medicines sometimes needed if the disease is “only nerves”?
   Damaged nerves can send extra, abnormal pain signals to the brain. Neuropathic pain can be severe and disabling. Medicines such as gabapentin, pregabalin, and duloxetine change how nerves send these signals and can greatly improve comfort. NCBI+2Palliative Care Network of Wisconsin+2

8. Will my child definitely need a wheelchair?
   Some people with CMTX5 will eventually need a wheelchair, at least for distance, while others may walk with braces or canes for many years. Early therapies and aids can delay or reduce disability, but the course differs between families. PubMed+1

9. Is school still possible for a child with CMTX5?
   Yes. With good hearing and vision support, mobility aids, and educational accommodations, many children can attend mainstream school. Early involvement of teachers and therapists is important.

10. Can girls be affected if the gene is on the X chromosome?
    Yes. Girls who carry the PRPS1 mutation may have mild symptoms because one of their X chromosomes is usually normal, but some can be more affected depending on X-inactivation. DNB+1

11. Does stress make symptoms worse?
    Stress does not change the gene, but it can increase pain perception, fatigue, and sleep problems. Stress management, counselling, and support can help people cope better.

12. Should family members be tested for the PRPS1 mutation?
    Genetic testing is a personal choice. It is often recommended for at-risk family members after proper counselling, especially when planning children or noticing early symptoms. thejcn.com+1

13. Can CMTX5 cause problems in the brain as well as nerves?
    Some PRPS1-related disorders (like Arts syndrome) can include developmental delay or brain changes, and there may be overlap in some families. Detailed evaluation by a neurologist is needed. DNB+1

14. Are there international centres that specialize in CMT?
    Yes, several major neuromuscular centres and CMT programs exist worldwide. They cannot cure CMTX5, but they can offer expert diagnosis, monitoring, and access to research studies. Muscular Dystrophy Association+1

15. What is the most important thing families can do right now?
    Build a strong care team (neurologist, therapists, audiology, ophthalmology, genetics), follow up regularly, keep up with therapy and supports, and look after mental health. Small, steady steps in daily care can make a big difference over time.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.